» Articles » PMID: 38770596

Veterans' 12-month PTSD and Depression Outcomes Following 2- and 3-week Intensive Cognitive Processing Therapy-based Treatment

Overview
Date 2024 May 21
PMID 38770596
Authors
Affiliations
Soon will be listed here.
Abstract

Growing evidence indicates that daily delivery of evidence-based PTSD treatments (e.g. Cognitive Processing Therapy (CPT)), as part of intensive PTSD treatment programmes (ITPs), is feasible and effective. Research has demonstrated that a 2-week CPT-based ITP can produce equivalent outcomes to a 3-week ITP, suggesting shorter treatment can also be highly effective. However, the extent to which ITP length and composition impact longer-term outcomes needs further study. We examined whether PTSD and depression symptoms 3-, 6-, and 12-months following completion of a 2-week ITP could be considered non-inferior, or equivalent, to those of a 3-week ITP. Data from 638 veterans who participated in a 2-week CPT-based ITP were evaluated against 496 veterans who participated in a 3-week CPT-based ITP. A Bayes factor approach was used to examine whether PTSD and depression severity outcomes of the 2-week ITP could be considered equivalent to the 3-week ITP. Participants across both ITPs reported large PTSD ( = 0.98) and moderate to large depression symptom reductions ( = 0.69) from baseline to 12-month follow-up. The PTSD and depression symptom reductions seen in the 2-week ITP were determined to be equivalent to those of the 3-week ITP. Low follow-up completion was a limitation. Future research might replicate the present findings using samples with greater follow-up rates and explore whether adjunctive services impact other relevant constructs, such as quality of life and functioning.

Citing Articles

Prebiotics as an adjunct therapy for posttraumatic stress disorder: a pilot randomized controlled trial.

Voigt R, Engen P, Villanueva M, Bambi S, Green S, Naqib A Front Neurosci. 2025; 18:1477519.

PMID: 39840022 PMC: 11747240. DOI: 10.3389/fnins.2024.1477519.

References
1.
Straud C, Siev J, Messer S, Zalta A . Examining military population and trauma type as moderators of treatment outcome for first-line psychotherapies for PTSD: A meta-analysis. J Anxiety Disord. 2019; 67:102133. PMC: 6739153. DOI: 10.1016/j.janxdis.2019.102133. View

2.
Bryan C, Russell H, Bryan A, Rozek D, Leifker F, Rugo K . Impact of Treatment Setting and Format on Symptom Severity Following Cognitive Processing Therapy for Posttraumatic Stress Disorder. Behav Ther. 2022; 53(4):673-685. DOI: 10.1016/j.beth.2022.01.014. View

3.
Resick P, Williams L, Suvak M, Monson C, Gradus J . Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J Consult Clin Psychol. 2011; 80(2):201-10. PMC: 3336190. DOI: 10.1037/a0026602. View

4.
Van Woudenberg C, Voorendonk E, Bongaerts H, Zoet H, Verhagen M, Lee C . Effectiveness of an intensive treatment programme combining prolonged exposure and eye movement desensitization and reprocessing for severe post-traumatic stress disorder. Eur J Psychotraumatol. 2018; 9(1):1487225. PMC: 6041781. DOI: 10.1080/20008198.2018.1487225. View

5.
Held P, Kovacevic M, Petrey K, Meade E, Pridgen S, Montes M . Treating posttraumatic stress disorder at home in a single week using 1-week virtual massed cognitive processing therapy. J Trauma Stress. 2022; 35(4):1215-1225. PMC: 9357038. DOI: 10.1002/jts.22831. View